Asked by: Adam Jogee (Labour - Newcastle-under-Lyme)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many hospitals have staff who are members of the Parkinson’s UK Excellence Network.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
No estimate has been made of the number of people with Parkinson's disease who have access to a Parkinson’s nurse in Newcastle-under-Lyme and Staffordshire. The Department does not hold data on how many hospitals have staff who are members of the Parkinson’s UK Excellence Network.
It is the responsibility of integrated care boards (ICBs) and local authorities to meet the care and support needs of people diagnosed with Parkinson’s disease. Patients living in the Surrey Heath constituency would be covered by either the NHS Frimley ICB or the NHS Surrey Heartlands ICB. ICBs are responsible for commissioning services to meet the healthcare needs of their local populations and, in doing so, we expect them to have regard to best practice guidance, such as that published by the National Institute for Health and Care Excellence.
This Government is committed to publishing a 10 Year Workforce Plan which will ensure the National Health Service has the right people in the right places, with the right skills to care for patients, when they need it.
The new NHS App will end the 8am rush by providing more flexibility in the way that people contact their general practitioner (GP), enabling better GP appointment booking as long as GPs make appointments available in the App. It will also help people to get care quicker without seeing their GP, for example improved self-care by going to a pharmacy or by self-referring into a specialist pathway or by providing remote consultations with specialists.
Asked by: Adam Jogee (Labour - Newcastle-under-Lyme)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) promote earlier detection of mouth cancer, (b) ensure (i) dentists, (ii) GPs and (iii) other frontline health professionals are trained to identify early warning signs and (c) reduce the time taken to (A) diagnose and (B) refer patients for treatment for mouth cancer.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
We know that cancer incidence, including mouth cancer incidence, is increasing. We know that more needs to be done to improve outcomes for patients with mouth cancer, including raising awareness of signs and symptoms and focusing on prevention, such as the introduction of the Tobacco and Vapes Bill.
Our forthcoming National Cancer Plan will have patients at its heart, and it will include further details on how we will speed up diagnosis and treatment, ensuring patients have access to the latest treatments and technology, and ultimately drive up this country’s cancer survival rates.
To support earlier and faster cancer diagnosis, we are now delivering additional checks, tests and scans at 170 community diagnostic centres.
Additionally, to help increase early detection of cancer, the Government has recently launched Jess’s Rule, an initiative that asks general practitioners (GPs) to think again if, after three appointments, they have been unable to diagnose a patient, or their symptoms have escalated.
We are also investing an additional £889 million in general practice, bringing total spend on the GP Contract to £13.2 billion in 2025/26. This will help to ensure we have a well-trained and well-equipped primary care service that can take the time to provide quality care to patients around the country.
Dentists and other dental professionals, including hygienists, routinely check the soft tissues of a patient’s mouth for signs of cancer during dental visits and as part of the check-up will make an assessment and record an individual’s oral cancer risk. Dentists will prioritise patients at a higher risk of oral cancer for more frequent recall and review in line with National Institute for Health and Care Excellence guidance.
Asked by: Adam Jogee (Labour - Newcastle-under-Lyme)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his policies of trends in the level of mouth cancer in the last ten years.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
We know that cancer incidence, including mouth cancer incidence, is increasing. We know that more needs to be done to improve outcomes for patients with mouth cancer, including raising awareness of signs and symptoms and focusing on prevention, such as the introduction of the Tobacco and Vapes Bill.
Our forthcoming National Cancer Plan will have patients at its heart, and it will include further details on how we will speed up diagnosis and treatment, ensuring patients have access to the latest treatments and technology, and ultimately drive up this country’s cancer survival rates.
To support earlier and faster cancer diagnosis, we are now delivering additional checks, tests and scans at 170 community diagnostic centres.
Additionally, to help increase early detection of cancer, the Government has recently launched Jess’s Rule, an initiative that asks general practitioners (GPs) to think again if, after three appointments, they have been unable to diagnose a patient, or their symptoms have escalated.
We are also investing an additional £889 million in general practice, bringing total spend on the GP Contract to £13.2 billion in 2025/26. This will help to ensure we have a well-trained and well-equipped primary care service that can take the time to provide quality care to patients around the country.
Dentists and other dental professionals, including hygienists, routinely check the soft tissues of a patient’s mouth for signs of cancer during dental visits and as part of the check-up will make an assessment and record an individual’s oral cancer risk. Dentists will prioritise patients at a higher risk of oral cancer for more frequent recall and review in line with National Institute for Health and Care Excellence guidance.
Asked by: Adam Jogee (Labour - Newcastle-under-Lyme)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the (a) number of referrals and (b) time taken to treat people with heart valve disease in each region.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Cutting elective care waiting times, including for cardiology services, is a key priority for the Government. The national waiting list for cardiology services has fallen by 59,307 since this Government came into office, with an increase in the proportion waiting less than 18 weeks, from 60.2% to 62.4%. But we know there is much more work to be done.
Cardiology is identified as a top priority for reform in our Elective Reform Plan, published in January 2025. Specific actions being taken to reform cardiology include increasing specialist input earlier in care pathways, developing standard pathways for common outpatient presentations such as palpitation, and increasing timely access to cardiac diagnostic tests, including through “straight to test” pathways.
To accelerate progress towards the Government’s ambition to reduce premature deaths from heart disease and stroke by 25% within a decade, we will publish a new cardiovascular disease modern service framework in 2026. The Department and NHS England are engaging widely throughout its development to ensure that we prioritise ambitious, evidence-led, and clinically informed approaches to prevention, treatment, and care.
My Rt. Hon. Friend, the Chancellor of the Exchequer, announced £600 million in the October statement to reduce diagnostic waiting lists, supporting new and expanded community diagnostic centres (CDCs), upgraded hospital diagnostic equipment, and digital diagnostic capabilities. NHS England's digital investments, including using artificial intelligence for cardiac imaging, have accelerated cardiology test reporting. From July 2024 to September 2025, CDCs performed 312,049 echocardiography and 281,869 electrocardiography tests, with many centres adopting innovative cardiac pathways to speed diagnosis and treatment, including for women.
The Government is committed to prioritising women’s health as we build a National Health Service fit for the future. We know that women deserve better, which is why we are delivering our commitment that never again will women’s health be neglected. The 2022 Women’s Health Strategy identified many important issues, including cardiology, which remain valid, so we now need to align the strategy with the 10-Year Health Plan and identify areas where we need to go further. That is why we are updating the Women’s Health Strategy, to assess the progress that has been made so far and to continue progressing delivery.
Asked by: Adam Jogee (Labour - Newcastle-under-Lyme)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure access to (a) diagnostic and (b) treatment options for women with heart valve disease.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Cutting elective care waiting times, including for cardiology services, is a key priority for the Government. The national waiting list for cardiology services has fallen by 59,307 since this Government came into office, with an increase in the proportion waiting less than 18 weeks, from 60.2% to 62.4%. But we know there is much more work to be done.
Cardiology is identified as a top priority for reform in our Elective Reform Plan, published in January 2025. Specific actions being taken to reform cardiology include increasing specialist input earlier in care pathways, developing standard pathways for common outpatient presentations such as palpitation, and increasing timely access to cardiac diagnostic tests, including through “straight to test” pathways.
To accelerate progress towards the Government’s ambition to reduce premature deaths from heart disease and stroke by 25% within a decade, we will publish a new cardiovascular disease modern service framework in 2026. The Department and NHS England are engaging widely throughout its development to ensure that we prioritise ambitious, evidence-led, and clinically informed approaches to prevention, treatment, and care.
My Rt. Hon. Friend, the Chancellor of the Exchequer, announced £600 million in the October statement to reduce diagnostic waiting lists, supporting new and expanded community diagnostic centres (CDCs), upgraded hospital diagnostic equipment, and digital diagnostic capabilities. NHS England's digital investments, including using artificial intelligence for cardiac imaging, have accelerated cardiology test reporting. From July 2024 to September 2025, CDCs performed 312,049 echocardiography and 281,869 electrocardiography tests, with many centres adopting innovative cardiac pathways to speed diagnosis and treatment, including for women.
The Government is committed to prioritising women’s health as we build a National Health Service fit for the future. We know that women deserve better, which is why we are delivering our commitment that never again will women’s health be neglected. The 2022 Women’s Health Strategy identified many important issues, including cardiology, which remain valid, so we now need to align the strategy with the 10-Year Health Plan and identify areas where we need to go further. That is why we are updating the Women’s Health Strategy, to assess the progress that has been made so far and to continue progressing delivery.
Asked by: Adam Jogee (Labour - Newcastle-under-Lyme)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make a comparative assessment of the adequacy of funding for research and innovation for (a) less survivable cancers and (b) other cancer types.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Research is crucial in tackling cancer, which is why the Department invests £1.6 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR). Cancer is one of the largest areas of spend at over £141.6 million in 2024/25, reflecting its high priority.
These investments are pivotal to informing efforts to improve cancer prevention, treatment, and outcomes. An example of this investment is the Imperial College London research on breath tests to detect less survivable cancers, with further information available at the following link:
https://imperialbrc.nihr.ac.uk/2023/06/05/imperial-led-uk-cancer-breath-tests-reach-final-stages/
Another example of Government investment was the launch of the NIHR’s national Brain Tumour Research Consortium in September 2024, which is bringing together researchers from a range of different disciplines and institutions with the aim of making scientific advances in how we prevent, detect, manage, and treat rare and less-survivable brain tumours in adults and children.
The NIHR continues to welcome funding applications for research into less common cancers and other cancer types. The forthcoming National Cancer Plan will include further details on how the National Health Service will improve diagnosis and outcomes for all cancer patients in England, including for less common cancers, and other cancer types.
Asked by: Adam Jogee (Labour - Newcastle-under-Lyme)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how much funding his Department has provided for community health services in (a) Newcastle-under-Lyme and (b) Staffordshire in the 2025-26 financial year.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
This data is only available at an integrated care board (ICB) level. Staffordshire and Stoke-on-Trent ICB is planning to spend £51.9 million in 2025/26 for community health services. This includes planned community care, hospices and palliative care.
Asked by: Adam Jogee (Labour - Newcastle-under-Lyme)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what plans his Department has to develop a neurology-specific implementation plan to support the 10 year Health Plan for England.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS England has established a Neurology Transformation Programme, a multi-year, clinically led programme, which has developed a new model of integrated care to support integrated care boards (ICBs) to deliver the right service, at the right time for all neurology patients. This programme is underway now and is due to conclude in March 2026.
The Neurology Transformation Programme focuses on providing access equitably across the country, care as close to home as possible, and early intervention to prevent illness and deterioration in patients with long-term neurological conditions. A toolkit is being developed to support ICBs to understand and implement this new model, which will include components on delivering acute neurology services, improving health equity in neurology, and improving community neurology services.
NHS England Specialised Commissioning published a revised National Neurology Service Specification in August 2025, which provides a detailed description of how patients can access specialised neurology care equitably wherever they are in England, particularly for specialised services that are not available in every part of the country.
There are currently no plans to develop a neurology-specific implementation plan to support the 10-Year Health Plan, although potential conditions and topics for the new modern service frameworks will be kept under review following the development of the first tranche of three referenced in the 10-Year Health Plan.